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Abstract
Background:  Protein structure prediction and computational protein design require efficient yet
sufficiently accurate descriptions of aqueous solvent. We continue to evaluate the performance of the
Coulomb/Accessible Surface Area (CASA) implicit solvent model, in combination with the Charmm19
molecular mechanics force field. We test a set of model parameters optimized earlier, and we also carry
out a new optimization in this work, using as a target a set of experimental stability changes for single point
mutations of various proteins and peptides. The optimization procedure is general, and could be used with
other force fields. The computation of stability changes requires a model for the unfolded state of the
protein. In our approach, this state is represented by tripeptide structures of the sequence Ala-X-Ala for
each amino acid type X. We followed an iterative optimization scheme which, at each cycle, optimizes the
solvation parameters and a set of tripeptide structures for the unfolded state. This protocol uses a set of
140 experimental stability mutations and a large set of tripeptide conformations to find the best tripeptide
structures and solvation parameters.
Results: Using the optimized parameters, we obtain a mean unsigned error of 2.28 kcal/mol for the
stability mutations. The performance of the CASA model is assessed by two further applications: (i)
calculation of protein-ligand binding affinities and (ii) computational protein design. For these two
applications, the previous parameters and the ones optimized here give a similar performance. For ligand
binding, we obtain reasonable agreement with a set of 55 experimental mutation data, with a mean
unsigned error of 1.76 kcal/mol with the new parameters and 1.47 kcal/mol with the earlier ones. We
show that the optimized CASA model is not inferior to the Generalized Born/Surface Area (GB/SA) model
for the prediction of these binding affinities. Likewise, the new parameters perform well for the design of
8 SH3 domain proteins where an average of 32.8% sequence identity relative to the native sequences was
achieved. Further, it was shown that the computed sequences have the character of naturally-occuring
homologues of the native sequences.
Conclusion: Overall, the two CASA variants explored here perform very well for a wide variety of
applications. Both variants provide an efficient solvent treatment for the computational engineering of
ligands and proteins.
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Background
Solvation effects play an important role in protein folding
and stability. Likewise, the processes of protein:protein
and protein:ligand binding are accompanied by effects
such as desolvation and rearrangement of solvent mole-
cules. These solvation effects can be calculated by explicit
solvent models, such as molecular dynamics simulations
using a sphere of water molecules [1]. For certain large-
scale applications, however, this explicit solvent treatment
is too time-consuming. In protein design, an enormous
number of amino acid sequences need to be considered
[2]. Likewise, the screening of a large library of ligand
molecules as a function of their binding affinity to a pro-
tein is a costly procedure and requires efficient methods.
To avoid these problems, implicit solvent models are
often used, which yield significant computational effi-
ciency [3]. They do not consider the solvent degrees of
freedom explicitly, but treat the solvent as a continuous
medium having the average properties of the real solvent.
Empirical methods, such as the solvent accessible surface
area (ASA) model [4], often provide simple and quick
ways of evaluating the solvation energy with an accuracy
comparable to theoretical models. ASA models have
become widely accepted within available implicit solvent
treatments and have been used successfully in many
applications, such as protein molecular dynamics [5-7],
structure prediction [8] and protein:ligand binding [9,10].
In the ASA approach, the solvation free energy of a solute
is expressed as a sum of atomic contributions, weighted by
their solvent-exposed area. The contribution of each atom
is quantified by a surface coefficient, which reflects the
hydrophobicity or hydrophilicity of the particular atom
type.
Apart from non-polar contributions to the solvation free
energy, such as the entropy cost for cavity formation and
van der Waals interactions, electrostatic contributions
play an important role. Due to the fitting of the ASA
model to experimental data, the electrostatic contribution
is partly incorporated into the parameters. However, espe-
cially when using a small number of atom types, it is nec-
essary to additionally calculate a screening energy, which
accounts for the shielding of protein-protein electrostatic
interactions by the high dielectric solvent. A simple
approach is to add a term that reduces the electrostatic
interactions between protein atoms by a constant factor, ε,
which plays the role of a dielectric constant. To balance
the two components of the solvent model, an overall
weight α is applied to the ASA term. This combined model
is known as the Coulomb/Accessible Surface Area (CASA)
model [3]. More accurate approaches for screening energy
calculations are the Generalized Born (GB) model [11,12]
and the Poisson-Boltzmann (PB) model [13-15]. A disad-
vantage of these methods, however, is that they are not
easily pairwise decomposable [16]: the energy is not
expressed as a sum over atom pairs. Further, they are rela-
tively time-consuming compared with surface area based
models.
The first set of atomic solvation parameters distinguishing
between different atom types was developed by Eisenberg
and McClachlan in 1986 [4]. They used octanol to water
transfer energies for 20 amino acids to derive solvation
coefficients for 5 atom types. Subsequently, a number of
studies have been devoted to the parameterization of the
atomic surface coefficients. They differ in the assignment
of atoms to characteristic groups and in the experimental
data that were used to fit the coefficients. Ooi et al. [17]
used 7 different atomic coefficients, fitted to experimental
free energies of solvation of small organic molecules. Fra-
ternali and van Gunsteren [6] restricted the atom types to
only two: one for carbon, representing the hydrophobic
effect, and one for both nitrogen and oxygen, representing
the hydrophilic effect. These two parameters were opti-
mized, such that the hydrophobic and hydrophilic sol-
vent-accessible surface areas in proteins obtained from
MD simulations matched those measured from the corre-
sponding X-ray structures. Later, several more highly-
parameterized ASA models [10,18,19] were developed,
which use up to 100 different atom types and large train-
ing sets of experimental solvation free energies for diverse
organic molecules.
In previous work [20], we optimized the CASA model for
side chain placement and mutagenesis. We modified the
atomic solvation parameters of Fraternali [6] by including
an additional surface coefficient for atoms in charged
groups, and by optimizing the dielectric constant ε and
the weight α of the surface term. The model was opti-
mized and tested using sidechain reconstruction calcula-
tions, protein solvation energies, and stability changes for
point mutations involving the insertion or removal of a
charged sidechain. In this paper, we continue to explore
the performance of the CASA model, pursuing two direc-
tions. First, we consider whether a specific treatment of
aromatic groups can lead to an improved parameteriza-
tion. Second, we consider a broader set of test calculations
than before. We again consider stability changes, but we
include a wider variety of mutations, most of which do
not affect charged groups. We consider the calculation of
protein:ligand binding free energy changes due to point
mutations, a very important application. So far, most lig-
and binding studies using ASA models used a large set of
atomic surface coefficients. Pei et al [10], for example,
used 100 atom types and reproduced the binding free
energies of a test set of 50 protein:ligand complexes with
a standard error of 2.0 kcal/mol. Our own model is much
less heavily parameterized, but yields a comparable accu-
racy.BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
Page 3 of 16
(page number not for citation purposes)
Finally, we perform automated protein design for eight
small proteins of the SH3 family. Computational protein
design is another area that requires good implicit solvent
models [2,21,22]. This approach can help engineer new
proteins as well as predict protein structure. It considers a
given backbone structure of a protein and predicts the
amino acid sequences that fold into it [23-30]. This infor-
mation can be used either to identify mutations that sta-
bilize a given structure or to assign the given 3D structure
to new sequences with yet undetermined protein struc-
tures. The protein design procedure is applied here to a
small test set of eight SH3 proteins and the performance
of the optimized solvation parameters is compared to that
of the earlier parameter set.
The newer CASA parameterization derived here treats aro-
matic groups as a specific group. All the model parameters
are then reoptimized from scratch. Most studies so far
have used experimental transfer free energies from octa-
nol or cyclohexane to water for small model molecules to
derive solvation parameters. However, organic solvents
are only a crude approximation of the protein interior [9].
A more recent study by Zhou et al. [31] used a database of
protein mutation experiments to develop atomic solva-
tion parameters. With these parameters, the binding free
energies of 21 protein-protein complexes were predicted
with an rms deviation of 2.3 kcal/mol. Likewise, Lomize
et al. [32] achieved very good agreement with experimen-
tal data using atomic solvation parameters based on pro-
tein stabilities. Here, we use a similar approach and derive
our newer solvation parameters from experimental pro-
tein and peptide stability changes. We employ a proce-
dure that attempts to match the computed stability
changes to the experimental values, using a set of 140
mutations. Simultaneously, the model for the unfolded
reference state of a protein is optimized: for each amino
acid type, a preferred unfolded conformation is chosen
from a large library of tripeptide fragments obtained from
various proteins.
The final parameter set yields improved performance for
protein stabilities, as expected. The newer and the earlier
parameters yield comparable, good performance for lig-
and binding and protein design. Given the importance of
implicit solvent models in the fields of structure-based
drug design, prediction of protein structure and protein
design, both of our optimized CASA models should be
valuable tools for a wide range of applications.
Results
CASA parameter optimization and stability calculations
In recent work, we optimized and tested the CASA model,
using just three atomic categories and performing
sidechain reconstruction and protein stability calcula-
tions. We refer to the corresponding set of atomic surface
coefficients as the "modified Fraternali", or MF parame-
ters (Table 1). Indeed, the starting point for the earlier
optimization was the parameter set of Fraternali & van
Gunsteren [6]. Here, we want to test the CASA model fur-
ther, and to explore whether a more extensive parameter-
ization will improve its performance. Our previous CASA
model [20] included only polar, unpolar and ionic atom
coefficients. The current protocol also distinguishes aro-
matic atoms as a separate group. This refined atom assign-
ment may be expected to improve the solvent model, as it
has been shown that aromatic groups have solvation
properties different from aliphatic groups [33]. With this
modification, we reoptimized all the model parameters
from scratch. We scanned a range of values for the four
different surface coefficients; additionally, three different
values for the dielectric constant ε in the Coulomb screen-
ing term (Eq. 2) were tested. A data set of 140 experimen-
tal stability mutations was used to adjust the parameters:
these data correspond to 7 different helical peptides and 3
different proteins. The protein mutations involve mainly
ionized residues, while the peptide mutations (which
were taken from helix propensity scales) cover the full
range of amino acids. In contrast to an earlier study by
Lomize et al. [32], which derived atomic solvation param-
eters based on stability data for the protein interior, and
in contrast to our previous study [20], this set of muta-
tions involves mainly solvent-exposed residues (14% bur-
ied residues).
To compute the stability of a protein, it is necessary to
construct a model for the unfolded state. Here, we assume
that sidechains do not interact with each other in the
unfolded state, and we describe the environment of each
sidechain with a simple tripeptide model. Each sidechain
thus interacts only with the local tripeptide backbone and
the solvent. For each amino acid type, one preferred struc-
ture was chosen from a large set of tripeptide conforma-
tions obtained from various proteins.
Since the choice of the preferred unfolded reference struc-
ture for each amino acid type also depends on the param-
eterization of the solvent model, the parameter
optimization had to proceed iteratively (Figure 1): (i) A
preferred tripeptide structure was chosen for each amino
acid using the current set of solvation parameters (ii); The
solvation parameters were adjusted to best reproduce the
experimental stability changes using the current set of ref-
erence structures. This was done based on the rms devia-
tion of the computed stability changes from the
experimental values.
Starting from the previously optimized solvation parame-
ters [6,20], the optimization procedure converged after 4
iteration cycles. Table 1 shows the set of surface coeffi-
cients chosen from the top-ranking results. We refer to theBMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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new set as the PHIA set (for "polar, hydrophobic, ionic,
aromatic"). Compared with the earlier, MF parameters,
the PHIA set shows a clear difference between the aro-
matic and the unpolar coefficient, a more positive ionic
coefficient and a slightly more negative unpolar coeffi-
cient. The experimental and computed stability changes
are compared in Figure 2. The correlation between the two
sets is modest, 43%. Nevertheless, the mean error is rea-
sonable, with an rms deviation of 2.94 kcal/mol for the
complete set of experimental values and a mean unsigned
error of 2.28 kcal/mol (Table 2). The rank ordering of the
data is characterized by a Spearman rank correlation of
29% [34]; the probability of obtaining this value by
chance is less than 0.001 (according to Student's test with
a t-value of 3.5 and 140 degrees of freedom [34]). The
PHIA results represent a significant improvement over the
performance of the MF parameters, which give an rms
deviation of 4.65 kcal/mol and a mean unsigned error of
3.56 kcal/mol. The dielectric constant for the new, PHIA
set of surface coefficients was set to 24. A higher dielectric
constant of 32 gives only insignificant improvement (rms
= 2.93 kcal/mol and mean = 2.27 kcal/mol), while a lower
value of 16 leads to noticeably poorer agreement with
experiment (rms = 3.23 kcal/mol and mean = 2.52 kcal/
mol).
In addition to the criterium of minimal deviation from
the experimental data, care was taken to select a parameter
set that makes sense physically. The ordering of the coeffi-
Table 1: Atomic solvation parameters (kcal/mol/Å2) for different 
atom types
atom type MF PHIA
unpolar 0.0119 -0.005
aromatic 0.0119 -0.04
polar -0.0597 -0.08
ionic -0.15 -0.10
MF: modified Fraternali parameters; PHIA: parameters optimized 
here.
Iterative parameter optimization Figure 1
Iterative parameter optimization. Iterative optimization of the atomic solvation parameters and the tripeptide models for 
the unfolded reference state of a protein.
Table 2: Rms and mean unsigned error (kcal/mol) for stability 
mutations
group of data number of mutations rms error mean error
all 140 2.94 2.28
peptides 67 2.68 2.20
proteins 73 3.17 2.34
charged 87 3.06 2.29
uncharged 54 2.72 2.22BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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cients should follow the expected preference of solvent
exposure of each atom group: unpolar < aromatic < polar
< ionized. Further, the coefficients of different groups
should be sufficiently separated from each other. The sur-
face coefficient of the unpolar atom group was allowed to
be slightly negative, as this led to better agreement with
the experimental data. To ensure that this does not lead to
unphysical behaviour, the surface coefficient was tested
on a propane dimer system. Studies on methane and neo-
propane association in water report an association free
energy of -1.0 and -2.7 kcal/mol, respectively [35,36].
Using values between 0.0119 and -0.01 kcal/mol/Å2 for
the nonpolar surface coefficient, the computed associa-
tion free energy varies from -2.75 to +0.09 kcal/mol. The
nonpolar coefficient of -0.005 kcal/mol/Å2 used here gives
an acceptable association free energy of -0.56 kcal/mol.
To verify that the parameters were not overly biased by the
optimization procedure, we performed cross-validation
tests (see Methods). Part of the data (30 mutations) were
omitted from the optimization process, then used to test
the error level. This led to very similar parameters and
errors compared to the original parameter optimization.
Specifically, one cross-validation run led to the following
optimized parameters (in kcal/mol/Å2; the PHIA values
obtained above are given in parentheses): aromatic: -0.08
(-0.04); ionic: -0.10 (-0.10); polar: -0.09 (-0.08); nonpo-
lar: -0.005 (-0.005). The optimal dielectric was 24, as
before. The mean and rms errors for the omitted data were
2.22 and 3.13 kcal/mol, respectively, compared to 2.11
and 2.70 for the optimization data. The mean and rms
errors with the PHIA parameters for the omitted data were
similar: 2.32 and 2.92 kcal/mol. The other cross-valida-
tion run led to the exact same atomic coefficients and die-
lectric constant, and to mean and rms errors for the
omitted data of 2.08 and 2.68 kcal/mol (compared to
2.16 and 2.71 kcal/mol with the PHIA set). Thus the opti-
mized parameters and the error levels are similar with and
without cross-validation, showing that the resulting
parameters are fairly robust.
The model performance shows a moderate dependence
on the system considered. The peptide models taken
alone lead to a slightly better agreement with the experi-
mental data (Table 2), which might be due to their simple
helical structure compared with a large protein system
Stability changes Figure 2
Stability changes. Calculated and experimental changes in stability upon mutation for 7 helical peptides and 3 proteins. The 
solid line corresponds to a (rather poor) linear fit; it and the dashed lines should be viewed as simple guides to help appreciate 
the error magnitudes.BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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(see also Figure 2). The performance of the uncharged
mutations is better than that of the charged ones (Table
2). This occurs partly because the proportion of charged
mutations is higher for the proteins (mostly charged
mutations).
Compared with the results of Lomize et al. [32], which
gave an rms deviation from experimental stability changes
of only 0.41 kcal/mol, the performance here is less good.
In their study, however, the solvation parameters were fit-
ted to a more restricted set of experimental data. Only bur-
ied, uncharged residues in α-helices and β-sheets of
proteins were used. In contrast, in our study, both charged
and uncharged, solvent-exposed and buried, and protein
and peptide mutations were included. Therefore, it can be
expected that our more varied set of mutations results in a
higher deviation from experiment.
Binding affinities
The performance of both the earlier, MF and the new,
PHIA solvation parameters was assessed on a large set of
experimental binding affinities and resistance mutations.
These data include 80 mutations in six different ligand-
protein systems: (i) tyrosyl-tRNA synthetase in complex
with tyrosine (TyrRS), (ii) aspartyl-tRNA synthetase in
complex with aspartate (AspRS), (iii) lysozyme in com-
plex with the antibody HyHel-10 (Lyso) and (iv) the com-
plex of the transmembrane glycoprotein CD4 with the
gp120 component of the HIV virus (CD4); (v) the
BPTI:trypsin complex; (vi) the chymotrypsin:BPTI com-
plex. A seventh system was also studied: the tyrosine
kinase Abl in complex with the drug imatinib. For this sys-
tem, information is only available on mutations leading
to resistance to the drug imatinib [37], while for the other
four systems, more precise values of the binding affinities
are available. The energy function was slightly different
from the one used for the stability mutations above. Here,
the dielectric constant (Eq. 2) ε was set to 16 and the
weight α of the surface area term was set to 0.5 (instead of
ε = 24, α = 1, above). These values gave improved per-
formance for the binding affinities.
For the first four systems, (i-v; 55 mutations in all), the
calculation of binding affinities followed a very simple
protocol that only optimizes the conformation of the side
chain in the mutated position, while the rotamers of the
remaining side chains are left unchanged apart from a
slight minimization. Further, the starting structures of the
ligand-bound state and the ligand-free state are assumed
to be identical except for the side chain at the mutated
position. Although this is a rather simple approach, the
resulting computed binding affinities are in reasonable
agreement with the experimental values. The mean
unsigned error for the differences in binding affinities
upon mutation is 1.76 kcal/mol with the PHIA parame-
ters, and 1.47 kcal/mol with the MF parameters (Table 3).
Thus, the performance of the two CASA variants for this
application is similar. The PHIA results for all mutations
are given in Additional File 1. The performance is slightly
poorer when charged residues are mutated. The more
complicated systems such as protein-antibody binding
(Lysozyme) or protein-protein binding (CD4) give
slightly higher deviations from experiment (see also Fig-
ure 3). The mean unsigned errors for the small molecule-
ligands (AspRS and TyrRS), combined, is 1.24 kcal/mol
with PHIA, while the protein-ligand systems (Lysozyme
and CD4), combined, give a mean unsigned error of 2.29
kcal/mol (Table 3).
Results were also computed for two other systems, the
BPTI:trypsin [38] and BPTI:chymotrypsin [39] complexes.
13 mutations at position 15 in BPTI were studied in each
case. The native residue is a lysine. One mutation was
excluded (K15W in BPTI:trypsin) due to a large van der
Waals contribution to the affinity change (see Methods),
leaving 25 mutations. With the simple protocol used
above, the agreement with experiment was poorer, with a
mean error of 3.4 kcal/mol for the 25 mutations. A
slightly different protocol was then tried. The entire BPTI
Table 3: Mean error (kcal/mol) for the binding free energies with CASA and GB/SA
data set number of mutationsb CASA GB-ACE GB-HCT reference
alla 55 (52/48) 1.76 2.39 1.96 [66–72]
chargeda 24 (23/20) 2.09 2.70 2.89
AspRS 9 (9/9) 1.86 3.40 1.25 [73]
TyrRS 15 (15/15) 0.62 0.80 1.13 [66–70]
Lyso 9 (9/7) 2.68 3.01 2.92 [71]
CD4 22 (19/17) 1.89 2.34 2.53 [72]
BPTIc 25 2.75 - - [38, 39]
aExcluding the BPTI complexes, which were computed with a slightly different protocol and for which GB data are not available. bFor GB-ACE and 
GB-HCT, some mutations were excluded due to unfavorable VdW contacts; the numbers of mutations (ACE/HCT) are in parentheses. 
cBPTI:trypsin and :chymotrypsin complexes.BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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was minimized, instead of just the mutated position (see
Methods). This led to improved agreement, with mean
errors of 2.68 and 2.81 kcal/mol for BPTI:trypsin and
BPTI:chymotrypsin, respectively: about the same level as
for the lysozyme:antibody complex. This illustrates the
need for more extensive structural relaxation with some
mutations. More generally, these two examples show that,
not surprisingly, with the simple energy functions and
conformational exploration used here, a certain amount
of system-specific parameter fitting and adjustment can be
necessary.
For the resistance mutations in Abl-kinase, good qualita-
tive agreement was achieved, in so far as all the mutated
proteins gave less favorable binding affinities than the
native protein (Table 4). For positions 22 and 86, the
computed difference between the mutant and native
binding free energies may be too small; the other three
values, however, are clearly consistent with the observed
resistance to imatinib binding.
There are several mutations that are badly predicted,
including R59A in the CD4:gp120 system and D101G and
K96M in the Lysozyme:antibody system (Figure 3). The
first two cases involve a large to small mutation, and all
three involve removal of a net charge; these processes
which might require a more extensive rearrangement of
the surrounding residues, as in the BPTI complexes
(where the native residue was a lysine in all 25 muta-
tions). In the simple protocol employed here, the rotam-
ers of the side chains in the vicinity of the mutation are
not reoptimized, and the slight minimization carried out
here might not be sufficient to model a realistic mutated
protein conformation. For the K96M case, we tried the
same protocol as for the BPTI cases, applying 50 steps of
Powell minimization to the entire lysozyme protein,
instead of just the mutated sidechain. This led to a com-
puted binding free energy change of +4.5 kcal/mol, much
closer to the experimental value of 7.9 kcal/mol. For one
other case, the D78A mutation in TyrRS, we employed a
much more extensive conformational search: all the
rotamers close to the mutation site were explored using a
stochastic search strategy; the error in the binding free
energy decreased from 1.9 kcal/mol to 0.8 kcal/mol (not
shown). These examples suggest that when the sidechain
charge and/or volume changes substantially, a more
sophisticated conformational sampling is required. More
work in this direction is underway.
On the whole, however, we obtain fair agreement with
experimental data using a very simple method. The over-
all mean unsigned error for the 80 mutations is 1.96 kcal/
mol; the rms error is 2.73 kcal/mol. The correlation
between the computed and measured data is 73%. The
rank ordering of the data is characterized by a Spearman
rank correlation of 70% [34]; the probability of obtaining
this value by chance is less than 0.001 (according to Stu-
dent's test with a t-value of 8.59 and 80 degrees of free-
dom [34]). Our errors are only slightly higher than those
reported by Pei et al., who obtained an rms error of 2.0
kcal/mol for the binding affinities of 50 protein-ligand
complexes. Likewise, the accuracy obtained here appears
comparable to that achieved by Guérois et al. [40] for
their charged mutations, although this subset was not
reported separately. Recently, Handel et al. [41] predicted
the stabilities of more than 1500 mutants to within 1 kcal/
mol. Partly, this improvement might be due to their more
sophisticated, all-atom, force field, which increases accu-
racy but makes their calculations almost an order of mag-
nitude more expensive, compared with the CHARMM19/
CASA level (the increased cost being due partly to the
explicit treatment of all hydrogens and partly to the need
for a more detailed rotamer library). Further, our data set
contains a higher percentage of charged mutations, which
makes predictions more demanding.
Table 4: Binding free energy differences for the ABL:imatinib 
complex with CASA and GB/SA
mutation CASA GB-ACE GB-HCT
L17V 1.74 1.00 0.80
Y22F 0.30 0.23 0.10
V58A 6.50 1.23 1.10
F86L 0.46 0.75 2.50
F128V 5.99 5.46 7.10
In kcal/mol.
Binding affinities Figure 3
Binding affinities. Calculated and experimental differences 
in  binding affinity upon mutation for 6 different  protein-lig-
and systems: Aspartyl- and Tyrosyl-tRNA  synthetases 
(AspRS+TyrRS), a Lysozyme-antibody  complex (Lyso), the 
CD4 complex with the gp120  component (CD4), and the 
BPTI complexes with  trypsin and chymotrypsin.
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As an additional reference, the performance of the opti-
mized CASA models was compared to that of a GB/SA
model, which should provide a more accurate treatment
of the electrostatic contribution to the solvation free
energy [42]. Only the 55 mutations for systems (i-v) were
studied. Two variants of the GB model were tested: (i) GB-
HCT [43] in combination with the Amber, all-atom force
field [44] and (ii) GB-ACE [45,46] with the CHARMM19
force field [47]. For the GB-HCT variant, the overall qual-
ity of the results is close to the CASA level, with a slightly
higher mean error (1.96 kcal/mol, Table 3). The GB-ACE
variant gives notably higher mean errors for all protein-
ligand systems. This might be due to the GB-ACE param-
eterization which is not optimized for this specific appli-
cation. The GB-HCT parameters were optimized
previously for computational sidechain placement and
protein mutagenesis [20]. Some differences between GB-
HCT and CASA might be due to the different force field
treatments, as Amber uses explicit hydrogens on all
atoms, while CHARMM19 uses implicit hydrogens for
unpolar atoms. The qualitative agreement with the exper-
imental resistance mutations for Abl:imatinib for the two
GB variants is comparable to that obtained using the opti-
mized CASA models (Table 4).
Protein design
In protein design, the amino acid side chains are mutated
and sequences are selected to optimize the folding free
energy, using a heuristic search algorithm. In our previous
protein design study [48], we obtained good results for 16
different globular proteins using the MF solvation param-
eters. Here, we consider a subset of those proteins, consist-
ing of 8 SH3 domains. These proteins are used to assess
the performance of the new, PHIA solvation parameters
for protein design. The protein design calculations were
carried out using our Proteins@Home distributed com-
puting platform, with the help of volunteers in several
countries. Proteins@Home is discribed in more detail
elsewhere [49].
For each protein, 450,000 sequences were generated and
amino acid identities relative to the native sequence were
calculated. Here, we give (consistent with the literature)
the full identities of the designed sequences, even though
Cys, Gly, and Pro were not allowed to mutate; see Tables
5 and 6. For further analysis, we selected two subsets of
the computed sequences: (i) the 40 sequences with the
highest identity scores relative to the native protein
("high-scoring sequences"); (ii) the 40 sequences with the
best folding free energies ("low energy sequences"). For
these two subsets, the mean sequence identities relative to
the corresponding native sequence are given in Table 5.
We will not discuss the mean identities over all 450,000
computed sequences, because the values lie very close to
those obtained for the low energy sequences. For the low
energy subset, the average sequence identity obtained
with the PHIA parameters is 32.8%, slightly lower than
the value obtained earlier with the MF parameters, 35.0%
[48]. For the eight proteins, the identities obtained with
PHIA range from 26.5% to 45.1%. The relative perform-
ance of the MF and PHIA parameters depends on the pro-
tein: since Hck and c-Src are better predicted with PHIA,
while 1gcqB, Crk, Abl, and especially Csk are better pre-
dicted with MF. Considering the subset of high-scoring
sequences, the PHIA parameters give results of roughly the
same quality as MF: the mean identities for this subset are
44.4% with PHIA, compared to 46.6% with MF.
With both the PHIA and the MF parameters, the identity
scores obtained for the 8 proteins lie within the range of
published average identity scores for redesigned proteins
[27,28,41,50,51]. In a protein design study by Jaramillo et
al. [50] sequence optimizations for 11 SH3 domains were
performed and resulted in an average sequence identity of
23.9%. Our energy-ranked PHIA sequences lie well above
this score, with a sequence identity of 32.8% averaged
over all 8 proteins. Recently, Saunders et al. [28] used a
refined protein design method and reported sequence
identities as high as 37% for 42 globular proteins. Consid-
ering the full sequence identities of our best-scoring
Table 5: Mean identities (%) for the computed sequences
MF (ε = 10) PHIA (ε = 14)
PDB code Name length low energy high score low energy high scoring
1gcq(B) Grb2 57 37.2 49.5 36.1 47.0
1gcq(C) Vav 69 45.6 55.0 45.1 52.4
1cka c-Crk 56 39.8 52.1 35.9 49.9
1shg alpha-spec. 57 26.9 37.6 26.5 39.5
1abo Abl kinase 58 37.7 48.5 34.7 45.8
1ad5 Hck kinase 58 22.6 38.4 23.6 36.1
1csk Csk 56 37.3 48.5 27.0 38.5
1fmk c-Src 60 32.4 43.5 33.8 45.9
average 34.9 46.6 32.8 44.4BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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sequences, both our parameter sets give results that lie
close to this value. Pokala and Handel [41] used an all-
atom force field and a GB/SA solvent model to redesign 8
proteins and achieved somewhat higher sequence identi-
ties, between 33.5 and 46.7%. This approach, however,
includes a negative design criterion, which constrains the
surface amino acid composition of the proteins to be
native-like. It also leads to an increase in computational
effort of about two orders of magnitude, compared with
the CASA solvent model and a united-atom force field
such as Charmm19.
Next, we addressed the question whether the sequences
computed with the new solvation parameters ressemble
naturally occuring sequences. As a reference, we created a
set of natural sequences in the following way. For each of
the 8 proteins, sequences from the SwissProt database
with a sequence identity of more than 60% relative to the
respective native sequence were retrieved. These
sequences were then combined into a large set consisting
of 94 sequences. Table 6 compares the average Blosum62
scores obtained for the natural sequence set with those for
the complete set of computed sequences and for our two
sets of high-ranking sequences (either low energy or high
Blosum62 sequences). A weighting scheme was applied to
the Blosum scores to account for the variability of each
amino acid within the natural sequences. This scheme
gives a greater weight to amino acids that are conserved
within the natural set. For a frequency of an amino acid of
more than 80% at a certain position within the natural
sequence set, a weight of 1 was assigned; for a frequency
between 50 and 80%, a weight of 0.75 was assigned; for a
frequency of less than 50%, a weight of 0.5 was assigned.
The Blosum62 scores show that the computed sequences
cover a considerable part of the natural sequence set. Fig-
ure 4 shows that the computed scores overlap with the
range of natural sequences. For most proteins, the
weighted average Blosum score lies below the cor-
respinding score for the natural sequence set, but is within
the range of the natural sequences. In one case (1gcqC),
the weighted average Blosum score even exceeds the value
of the natural set. This indicates that the computed
sequences do indeed show native-like characteristics and
behave like distant homologues of the native sequences.
Discussion
Simple, efficient, solvent models are of great importance
in protein modelling and structural bioinformatics. Here,
we have continued to explore the performance of the
CASA solvent model, in two directions. First, we consid-
ered a variant of increased complexity, where aromatic
atoms are treated as a separate group. Our previous
approach [20] did not distinguish between unpolar and
aromatic atoms. Indeed, the solvation properties of aro-
matic groups are rather different from other nonpolar
groups found in proteins. For this variant, we reparame-
terized the model completely, leading to the PHIA param-
eter set. Second, we applied the CASA model to a wider set
of applications than previously. We considered protein
stability changes associated with point mutations, includ-
ing all amino acid types (in contrast to our previous work
[20]). We also considered protein:ligand binding, an
especially important application. Finally, we performed
complete protein redesign with the new parameters.
For the new, PHIA parameterization, four different atom
types were considered for the atomic surface coefficients:
unpolar, aromatic, polar and ionized atoms. The solva-
tion parameters were fitted to a set of 140 experimental
stability changes for protein and peptide mutations. Pro-
tein stabilities were calculated using an unfolded reference
state modelled by a collection of tripeptide structures.
These reference structures were taken from a large library
of structural fragments from six different proteins. Starting
from the earlier, MF solvation parameters [6,20], an itera-
tive procedure was employed, which optimizes, at each
cycle, both the solvation parameters and the model for the
unfolded reference state of a protein. Atomic parameters
were chosen that gave a minimal deviation from the
experimental data and also represent the expected relative
hydrophobicities of the atom groups. The selected param-
eter set gives a mean unsigned error of 2.28 kcal/mol for
the 140 stability mutations, compared to 3.56 kcal/mol
Table 6: Blosum scores for computed and natural sequences
PDB code natural sequences computed (all) low energy high scoring
1gcqB 98.2 67.8 74.0 100.8
1gcqC 43.2 110.5 121.6 141.2
1cka 99.1 57.8 71.2 104.1
1shg 95.9 35.7 38.5 65.2
1abo 89.0 67.3 71.4 98.3
1ad5 111.3 35.5 36.8 75.0
1csk 87.7 60.9 63.0 90.5
1fmk 122.2 56.2 64.2 92.5BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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with the MF parameters. Cross-validation tests gave simi-
lar parameter values and similar error levels.
For the binding calculations, over 50 experimental muta-
tions in 5 different protein-ligand systems were used,
including both small molecule ligands and protein-pro-
tein complexes. The calculated differences in binding free
energy are in reasonable agreement with the experimental
data, with both CASA variants. The mean unsigned error
is 1.76 kcal/mol with the PHIA parameters and 1.47 kcal/
mol with the MF parameters. It was also shown that the
optimized CASA models are not inferior to methods such
as GB-ACE/SA or GB-HCT/SA, which treat the electrostatic
contribution to solvation more accurately. Two additional
protein-protein complexes (BPTI:trypsin, BPTI:chymot-
rypsin) required a slightly modified protocol to give com-
parable error levels.
Protein design was carried out for eight SH3 domain pro-
teins and the performance of the PHIA parameters was
compared with that of the MF parameters. On average,
slightly lower sequence identities with the native
sequence were achieved using the new, PHIA parameters.
Differences, however, are small, and the performance
depends on the particular protein. On the whole, both
parameter sets give sequences of comparable quality,
which are competitive with recently published results for
designed proteins. Further, the computed sequences were
found to have the character of naturally occuring, distant
homologues of the native sequences.
Conclusion
Overall, the CASA model performs well for a wide variety
of applications. The PHIA parameters, specifically opti-
mized here for protein stability, give a distinct improve-
ment over the earlier, MF parameters for this application.
For ligand binding and protein design, the specific treat-
ment of aromatic groups in the PHIA parameterization
did not lead to an improvement in performance. Rather,
the two parameter sets perform well for both applications,
with the exact relative performance dependening on the
particular system. Both variants provide an efficient tool
for the computational engineering of ligands and pro-
teins.
Methods
Effective energy function
The effective free energy function we used in our calcula-
tions takes the following form:
E = Ebonds + EAngl + EDihe + Eimpr + EvdW + ECoul + Esolv
(1)
Comparison of Blosum scores for natural and computed sequences Figure 4
Comparison of Blosum scores for natural and computed sequences. For each protein (denoted by the respective 
PDB code), the vertical lines represent the range of scores within the natural sequence set (left) and the computed sequence 
set (right). The average score is shown as circles and as triangles for the natural and the computed sequences, respectively.
50
100
150
200
250
B
l
o
s
u
m
6
2
 
S
c
o
r
e
s
1gcqB
1gcqC
1cka 1shg
1abo 1fmk 1csk 1ad5BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
Page 11 of 16
(page number not for citation purposes)
The first six terms represent the protein internal energy
and are taken from the CHARMM19 empirical energy
function [47]: a covalent bond energy term, a bond angle
energy term, a torsion energy term, an improper dihedral
energy term which maintains the chirality or planarity of
certain atom centres, a Van der Waals energy term and a
Coulomb electrostatic energy term. The last term, Esolv,
models the effect of the solvent, and represent either a
CASA term or a GB term in this study. When using the GB
variant HCT for the solvent term, force field parameters
for the energy function were taken from Amber [44] (see
below).
Coulomb/Accessible Surface Area (CASA) model
This implicit solvent model uses a screened Coulomb
energy term and a solvent accessible surface energy term
[3]. The former describes the dielectric screening of sol-
vent-solute interactions. It reduces interactions between
solute atoms by a constant factor ε to account for the
shielding by the high dielectric solvent. The latter term
represents local solute-solvent interactions, such as van
der Waals energy and cavity energy (creating a cavity
against the solvent pressure and reorganization of solvent
molecules around the solute), that are assumed to be pro-
portional to the solvent accessible surface area of the sol-
ute atoms. The equation for the solvation free energy takes
the following form:
where Ai is the exposed solvent accessible surface area of
atom i, and the summation is over all atoms in the solute;
σi (measured in kcal/mol/Å2) is a parameter that depends
on the nature of atom i and reflects each atom's preference
to be exposed or hidden from solvent; α  is an overall
weight applied to the surface energy term. Surface areas
were computed by the Lee and Richards algorithm [52],
implemented in the XPLOR program [53], using a 1.5 Å
probe radius. The solute atoms were divided into 4 groups
with characteristic surface coefficients σi: unpolar, aro-
matic, polar and ionic. Hydrogen atoms were assigned a
surface coefficient of 0. The weight α was not optimized
during the parameter scans (fixed to 1) but was adjusted
in subsequent applications. For the protein design calcu-
lations (see below), a value of 1 was used. For the ligand-
binding calculations (below), a value of 0.5 worked best.
The dielectric constant was optimized in the parameter
scans, with a value of 24 working well for the stability
mutations. Values of 16 and 14 were used, respectively,
for the ligand-binding and protein design calculations.
Generalized Born/Surface Area (GB/SA) model
A more sophisticated description of electrostatic interac-
tions in a heterogeneous dielectric medium is provided by
the Poisson-Boltzmann (PB) equation [13-15]. Given a
spatial charge distribution in an environment with one or
more dielectric constants, the electrostatic potential can
be calculated. The cost involved in solving the PB equa-
tion numerically, however, limits its use. A more efficient
alternative is the Generalized Born (GB) model [11,12],
which is based on PB theory but replaces the solution to
the electrostatic potential by an approximate calculation
of the solvent-induced reaction field energy. In the GB/SA
method, the electrostatic contribution to the solvation
free energy is described by a GB term, while the non-polar
contribution is modelled as proportional to the solvent
accessible surface area of the solute. The two contribu-
tions are balanced by a factor σ applied to the surface area
term:
where EGB is the GB term consisting of a self-energy term
and an interaction term as described elsewhere [14,20]; Ai
is the exposed solvent accessible surface area of atom i,
and the summation is over all atoms in the solute. In
effect, a single surface coefficient σ is used for all atom
types.
Calculation of stability changes
In general, introducing a mutation changes the stability of
a protein. Here, differences between the stability of a
mutant protein and the native protein were calculated.
The stability of each protein is computed as the difference
in free energy between the folded state and an unfolded
reference state. The free energy change upon mutating a
protein is thus:
where Gmut, Gnat are the free energies of the mutant and
native protein, respectively, and  ,   are the free
energies of the unfolded reference state for the mutant
and native protein, respectively. The free energy of each
state is evaluated using the effective energy function given
in equation (1) with the solvent contribution being repre-
sented by a CASA term. The nonbonded interactions were
cut off at a distance of 10 Å between atoms using a shifting
and a switching function for electrostatic and van der
Waals interactions, respectively.
The native structures for the folded state were taken from
the Protein Data Bank (PDB) [54] with the structure codes
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2LZM, 2RN2 and 1STN, respectively. The side chains were
slightly minimized prior to any energy evaluation. For the
peptide mutations, experimental structures are not availa-
ble, and models were built using the SwissPDB viewer
[55], which constructs an ideal α  helix from a given
sequence. After side chain minimization of the helix mod-
els, the structures were treated identically to the protein
structures.
The corresponding mutant protein and peptide structures
were created by replacing the side chain at the mutated
position with the mutant side chain while maintaining all
other atom coordinates. The coordinates for the mutant
side chain were taken from the Tuffery rotamer library
[56]. For each rotamer, the side chain was minimized (30
steps of Powell minimization), with the backbone fixed,
and the energy of the mutant protein was evaluated. The
mutant side chain rotamer giving the lowest energy for the
mutant protein was retained. For the native structures, the
side chain conformation at the position to be mutated
was kept as in the crystal structure and only subjected to a
short minimization (30 steps). In some cases, unfavoura-
ble van der Waals contacts in the proteins occured upon
mutation. These data were considered as outliers and were
not used for parameter adjustment (see below).
The experimental stability changes for the protein muta-
tions were taken from the ProTherm database [57]. For
the peptide stability changes, experimental helix propen-
sity scales were used. The sequences of the various peptide
systems are given below, with the mutated position
denoted by X:
pepT1: SSDVSTAQXAAYKLHED [58],
KEAKE: YEAAAKEAXAKEAAAKA [59],
K2AE2: YSEEEEKAKKAXAEEAEKKKK [60],
VAR: KETAAAKFERQHMDS [61],
PAD: YKAAAAKAAXAKAAAAK [62],
KAL: YSEEEEKKKKXEEEEKKKK [63],
SH1: AETAAAKFERQHM [64],
SH2: KETAAAKFERAHA [64]
Unfolded state
In the unfolded state of a protein, it is assumed that amino
acid side chains do not interact with each other, but only
with nearby backbone groups and with solvent. This situ-
ation can be modelled by a collection of n tripeptide struc-
tures with the sequence Ala-X-Ala; n is the number of
amino acids in the protein. For each amino acid type X, a
number of possible structures with different backbone
and side chain conformations were considered. These
structures were extracted from various positions in the X-
ray structures of 6 different proteins taken from the PDB
[54]: lysozyme (2LZM), bovine pancreatic trypsin inhibi-
tor (4PTI), staphylococcal nuclease (1STN), α-toxin
(1PTX), ribonuclease A (2RN2) and cyclophilin (2CPL).
In each tripeptide structure, the side chain X was slightly
minimized with respect to itself and the backbone of the
whole tripeptide. To choose the optimal tripeptide struc-
ture for each amino acid type, the interaction between the
respective side chain and the tripeptide backbone served
as a criterium. Thus, for each amino acid type X, the
tripeptide structure giving the lowest interaction energy
was taken to represent the preferred structure for X in the
unfolded state. The total free energy of the unfolded state
is obtained by summing the contributions, EX, of the n
individual amino acids of the protein. When comparing
the folding free energies of two sequences, only sidechain
– sidechain and sidechain – backbone interactions are
taken into account. Interactions between different por-
tions of the backbone cancel, both in the folded and the
unfolded state, so that no important interactions are
missed through the tripeptide unfolded model.
Iterative optimization
Since the choice of the reference structure for each amino
acid depends on the set of parameters used in the CASA
model, the solvent parameters and tripeptide structures
had to be optimized iteratively (Figure 1). As a starting
point for optimization, we took the surface parameters
developed by Fraternali and van Gunsteren [6], supple-
mented by an additional surface coefficient for ionic
atoms [20]. In this initial parameter set, aromatic atoms
were assigned the same surface coefficient as unpolar
atoms.
The atom groups were assigned as follows: (i) unpolar: all
alkane carbons, the carbonyl carbons of the protein back-
bone, and S; (ii) aromatic: Trp, Phe and Tyr aromatic ring
carbons and nitrogens; (iii) polar: N/O atoms not belong-
ing to ionized groups, N-C-N group in the His ring; (iv)
ionic: guanidinium group of Arg, carboxyl group of Asp/
Glu, N-C-N group in the ring for protonated His.
Using this solvation model, a first choice of reference
structures was made. Then, stability changes were calcu-
lated according to equation (3) using the current set of ref-
erence structures. These stability changes were calculated
for all combinations of surface parameters within a range
of values given below (Table 7). Thus, for each combina-
tion of parameters, a set of ∆∆G values was obtained; a
mean unsigned error and an rms deviation from the
experimental stability changes were determined. The rmsBMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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deviation was used as a score for the performance of a
given surface parameter combination. From the top-scor-
ing parameter sets, a physically meaningful set was chosen
and used as a new starting point for the next iterative opti-
mization cycle. This procedure was repeated until no fur-
ther significant change in the ranking of the parameter
combinations occurred.
Cross validation
The optimization procedure was tested for bias and over-
fitting by the following cross-validation procedure. 30 of
the 140 mutants were chosen randomly and left out of the
optimization. The reference structures were taken from
the above, iterative optimization and kept fixed. Parame-
ter scanning was then performed, leading to several good
quality parameter sets. The mean errors were then com-
puted for the omitted, or "test" data. This procedure was
done twice, with two distinct sets of mutations omitted
from the optimization. The parameter sets and error levels
from these two runs were similar to each other and to the
iterative optimization described above, showing that the
optimization is not subject to excessive overfitting or bias.
Binding affinities
Binding affinities were calculated for 5 different ligand-
protein systems taken from the PDB [54] and a number of
their mutants: (i) tyrosine kinase Abl in complex with
imatinib (1OPJ), (ii) Tyrosyl-tRNA synthetase in complex
with tyrosine (4TS1), (iii) Aspartyl-tRNA synthetase in
complex with aspartate (1IL2), (iv) Lysozyme in complex
with the antibody HyHel-10 (3HFM) and (v) the complex
of the glycoprotein CD4 with the gp120 component of
the HIV virus (1G9M). As starting structures, the ligand-
bound X-ray structures of these 5 proteins were used. The
system (iii) was truncated to a 30Å sphere around the lig-
and; systems (ii), (iv) and (v) were truncated to 20 Å
spheres around the ligand, and for system (i) the untrun-
cated structure of chain B was used. The mutant structures
were created by replacing the side chain at the relevant
position with a rotamer of the mutant side chain from the
Tuffery library [56].
A simple protocol was adopted for the energy evaluation:
The side chain at the mutated position was subjected to 50
steps of minimization with respect to itself and to all other
side chains with the backbone kept fixed. During this
minimization, all sidechains were allowed to adjust to the
introduced mutation but otherwise inter-sidechain inter-
actions were excluded. The energy of this slightly adjusted
protein conformation was taken as the ligand-bound
energy. For the ligand-free state, the ligand was removed,
the side chains were again minimized and the energy of
this conformation was taken. For the mutated sidechain,
all rotamers from the library were considered, and the
lowest energy for the ligand-bound and ligand-free states,
respectively, was retained. In the native structure, the
rotamer at the position to be mutated was not varied, as it
is assumed that the X-ray structure already represents a
low energy conformation.
Three different solvent treatments were employed in this
protocol:
(1) The CASA model as described above using the param-
eters optimized earlier [20], with a weight factor α of 0.5
and a dielectric constant ε of 16. We obtained good results
for sidechain placement and stability changes in our pre-
vious work [20] using these values.
(2) The CASA model with the parameters optimized here,
with the same weight factor α of 0.5 and dielectric con-
stant ε of 16. These values of α and ε were chosen because
they gave the best agreement with the experimental bind-
ing affinities.
(3) A Generalized Born/Surface Area (GB/SA) model with
a weight factor σ of -0.05 kcal/mol/Å2 for the surface term
and a dielectric constant ε of 8.0.
Mutations for which the van der Waals energy contributed
more than 10 kcal/mol to the difference in binding energy
were considered outliers and were not included in the
results. These contributions are probably due to unfavour-
able contacts that are not resolved by the simple minimi-
zation protocol used here.
For two additional systems, a slightly different protocol
gave distinctly better results. These were the BPTI:trypsin
and BPTI:chymotrypsin complexes [38,39]. Several BPTI
mutations at position 15 (within the interface) were con-
sidered. Instead of minimizing just the mutated
sidechain, as above, we minimized the entire BPTI protein
for each choice of rotamer (for 50 steps, as above).
Protein design
The energy function for protein design corresponds to
Equation (1), with the solvation contribution described
Table 7: Range of solvation parameters (kcal/mol/Å2) and 
dielectric values ε scanned during the iterative optimization
atom type range interval
unpolar -0.005 to 0.01 0.005
aromatic -0.08, -0.06 to 0.01 0.01
polar -0.12, -0.10 to -0.04 0.01
ionic -0.20, -0.18 to -0.10 0.01
ε 16 to 32 8BMC Bioinformatics 2008, 9:148 http://www.biomedcentral.com/1471-2105/9/148
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by a CASA term. The interaction energy between each pos-
sible combination of sidechain pairs, or between a
sidechain and the backbone, are precomputed and stored
in an energy matrix. For a given sidechain pair, this calcu-
lation includes all possible combinations of both amino
acid types and rotamer values. Once the energy matrix is
computed, the amino acid sequence is optimized in a sec-
ond stage, through cycles of random mutations and steep-
est-descent minimization. This heuristic procedure was
developed and validated by Wernisch et al. [24]. A "heu-
ristic cycle" proceeds as follows. An initial amino acid
sequence and set of sidechain rotamers are chosen ran-
domly. These are improved in a stepwise way. At a given
amino acid position i, the best amino acid type and
rotamer are selected, with the rest of the sequence and
structure held fixed. The same is done for the following
position i + 1, and so on, performing multiple passes over
the amino acid sequence until the energy no longer
improves (or a given, large number of passes is reached).
The final sequence, rotamer set, and energy are output,
ending the cycle. For the design calculations below, we
performed 450,000 heuristic cycles for each protein.
Disulfide-bonded cysteines, glycines and prolines are
expected to have a special effect on the protein's folded
and unfolded state structures, which may not be accu-
rately captured by our method. Therefore, if these amino
acids were present in the native sequence, they were held
fixed; all other amino acids were allowed to mutate freely.
The calculations were done using our Proteins@Home
distributed computing platform. This allows us to use the
computers of several thousand volunteers in over 70
countries. Proteins@Home is based on the Berkeley Open
Infrastructure for Network Computing, BOINC [65]. The
Proteins@Home platform and project will be described in
detail elsewhere [49].
The model for the unfolded state of a protein is analogous
to that described above, employing a collection of tripep-
tide structures. However, an additional, empirical correc-
tion was added to the unfolded state energies. For each
amino acid type, the correction is defined and optimized
to provide a realistic overall amino acid composition of
the resulting sequences. More details of this procedure are
given elsewhere [48]. The precise values of the reference
energies are given in Table 8. The dielectric constant was
set to ε = 14; the weight of the surface term (Eq. 2) was set
to α = 1. Notice that our earlier design calculations with
the MF parameters [48] used ε = 10, α = 1, and different
reference energies.
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